Overview: Research on monoclonal antibodies to protect against COVID-19 variants

COVID SCIENCE-Researchers seek powerful antibody against many variants; breakthrough cases may be less infectious Two separate research teams last week reported on laboratory tests of monoclonal antibodies that appear to protect against a broad range of COVID-19 virus variants. One study, published on Wednesday in The New England Journal of Medicine bit.ly/3kgzEZU, identified "high-level, broad-spectrum" antibodies in blood samples from survivors of the original SARS outbreak in 2003 who recently received the Pfizer/BioNTech vaccine against SARS-CoV-2, the virus that causes COVID-19. In test tube experiments, some of the SARS survivors' antibodies induced by the vaccine could neutralize not only all of the current SARS-CoV-2 variants of concern, but also five viruses that have been identified in bats and pangolins and that have the potential to cause human infection. Nancy Lapid Yahoo

Aug 23 (Reuters) - Here is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

Researchers working toward one vaccine for many variants

Two separate research teams last week reported on laboratory tests of monoclonal antibodies that appear to protect against a broad range of COVID-19 virus variants. ...